Anbio Biotechnology Limited (N3B)
Market Closed
17 Jul, 20:00
XFRA 
€
8. 05
+0.35
+4.5455%
€
1.06B Market Cap
- P/E Ratio
- Div Yield
5 Volume
- Eps
€ 7.7
Previous Close Want to track N3B and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Anbio Biotechnology Limited (N3B) Statistics
Valuation metrics
Market Cap 1.06B
Enterprise value 767.8M
Trailing P/E (ttm) 158.46
Forward P/E -
PEG ratio -
Price/Sales (ttm) 113.76
Price/Book (mrq) 35.1
Enterprise Value/Revenue 103.19
Enterprise Value/EBITDA 145.58
Overview
Shares outstanding 43.89M
Float 39.69M
Shares short -
% Held by insiders 0.05%
% Held by institutions 0.05%
Average volume (10 days) 4
Average volume (90 days) 4
Price summary
52-Week low 7.7
52-Week high 43.6
Beta -
50-Day moving average 21.02
200-Day moving average 23.81
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.74%
Operating margin 0.59%
Operational effectiveness
Return on assets 0.15%
Return on equity 0.27%
Income Statement
Revenue (ttm) 7.44M
Revenue per share (ttm) 0.2
Quarterly revenue growth (yoy) 0.74%
Gross profit (ttm) 6.49M
EBITDA 5.27M
Net income to common (ttm) 5.51M
Diluted EPS (ttm) 0.13
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 10.24M
Total cash per share (mrq) 0.27
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 344.31%
Book value per share (mrq) 0.59
Cash Flow
Cash flow statement -5.8M
Levered free cash flow (LFCF) -8.27M
